Skip to main content

The use of electronic consent (e-Consent) in randomised trials

Peter Jüni

About the Collection:

Whilst e-Consent was permitted from a regulatory and ethical perspective previously, its use has increased more recently, not least due to the Covid-19 pandemic and the need to move some clinical trial processes remotely. Whilst there may be benefits to implementing e-Consent, it is not without challenges and as more people engage in implementing e-Consent, Trials is keen to share trialists’ experiences, innovations, case studies and methodological research into this emerging area.

This collection is no longer accepting submissions

Edited by:

Peter Jüni, MD, FESC, University of Oxford, United Kingdom
Tianjing Li, PhD, University of Colorado Denver, United States of America 
Shaun Treweek, PhD, University of Aberdeen, United Kingdom


  1. Use of electronic methods to support informed consent (‘eConsent’) is increasingly popular in clinical research. This commentary reports the approach taken to implement electronic consent methods and subsequen...

    Authors: William J Cragg, Chris Taylor, Lauren Moreau, Howard Collier, Rachael Gilberts, Niamh McKigney, Joanna Dennett, Sandra Graca, Ian Wheeler, Liam Bishop, Adam Barrett, Suzanne Hartley, John P Greenwood, Peter P Swoboda and Amanda J Farrin
    Citation: Trials 2024 25:310
    Content type: Commentary Published on:

  2. During the COVID-19 pandemic, in-person healthcare visits were reduced. Consequently, trial teams needed to consider implementing remote methods for conducting clinical trials, including e-Consent. Although so...

    Authors: E. J. Mitchell, D. Appelbe, A. Bravery, L. Culliford, H. Evans, A. J. Farrin, K. Gillies, K. Hood, S. B. Love, M. R. Sydes, P. R. Williamson and N. Wakefield
    Citation: Trials 2023 24:657
    Content type: Research Published on: